Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

UNLOCKING SAFE REMEDIES: Preclinical Toxicological Evaluation of the Hydroethanolic Extract of Spondias mombin in Rodents

View through CrossRef
Abstract Background : Toxicity accounts for nearly one-third of candidate drug attrition, underscoring the need for robust preclinical toxicological evaluation early in the drug development pipeline. To the best of our knowledge, this is the first comprehensive toxicological profiling of Spondias mombin hydroethanolic leaf extract in rodent models in Nigeria. Traditionally used for the treatment of dysentery, gonorrhea, wounds, and anemia, S. mombin hydroethanolic extract warrants systematic evaluation to support its safe therapeutic use and guide the optimization of lead compounds. Methods : Acute toxicity was assessed in mice using a limit test following a single oral dose and a 14-day observation period. Subacute and subchronic toxicity were evaluated in female Wistar rats (n = 6/group and n=10/group) administered 40, 200, or 1000 mg/kg/day of extract for 28 and 60 days, respectively. A control group received distilled water. Hematological and biochemical analyses were conducted post-treatment before humane euthanasia. Results : No mortality or observable signs of toxicity were recorded at doses up to 2000 mg/kg. The extract significantly reduced white blood cell count, absolute lymphocytes, and total bilirubin (WBC: 5.60 × 10³/µL vs. 9.35 × 10³/µL; lymphocytes: 2.08 × 10³/µL vs. 4.28 × 10³/µL; bilirubin: 1.99 µmol/L vs. 2.39 µmol/L). S. mombin extract also exhibited dose-dependent increases in red blood cell and hemoglobin counts, alongside reductions in AST, ALT, and ALP levels in the subacute phase. In the subchronic study, S. mombin significantly reduced total cholesterol (40 mg/kg: 1.96 mmol/L vs. control: 2.85 mmol/L) and bilirubin (1000 mg/kg: 10.69 µmol/L vs. control: 22.58 µmol/L). Conclusion : The validated safety profile of S. mombin hydroethanolic leaf extract supports its continued ethnomedicinal use and highlights its promise as a candidate for further pharmacological development—particularly as a potential hematinic, anti-infective, and hepatoprotective agent.
Title: UNLOCKING SAFE REMEDIES: Preclinical Toxicological Evaluation of the Hydroethanolic Extract of Spondias mombin in Rodents
Description:
Abstract Background : Toxicity accounts for nearly one-third of candidate drug attrition, underscoring the need for robust preclinical toxicological evaluation early in the drug development pipeline.
To the best of our knowledge, this is the first comprehensive toxicological profiling of Spondias mombin hydroethanolic leaf extract in rodent models in Nigeria.
Traditionally used for the treatment of dysentery, gonorrhea, wounds, and anemia, S.
mombin hydroethanolic extract warrants systematic evaluation to support its safe therapeutic use and guide the optimization of lead compounds.
Methods : Acute toxicity was assessed in mice using a limit test following a single oral dose and a 14-day observation period.
Subacute and subchronic toxicity were evaluated in female Wistar rats (n = 6/group and n=10/group) administered 40, 200, or 1000 mg/kg/day of extract for 28 and 60 days, respectively.
A control group received distilled water.
Hematological and biochemical analyses were conducted post-treatment before humane euthanasia.
Results : No mortality or observable signs of toxicity were recorded at doses up to 2000 mg/kg.
The extract significantly reduced white blood cell count, absolute lymphocytes, and total bilirubin (WBC: 5.
60 × 10³/µL vs.
9.
35 × 10³/µL; lymphocytes: 2.
08 × 10³/µL vs.
4.
28 × 10³/µL; bilirubin: 1.
99 µmol/L vs.
2.
39 µmol/L).
S.
mombin extract also exhibited dose-dependent increases in red blood cell and hemoglobin counts, alongside reductions in AST, ALT, and ALP levels in the subacute phase.
In the subchronic study, S.
mombin significantly reduced total cholesterol (40 mg/kg: 1.
96 mmol/L vs.
control: 2.
85 mmol/L) and bilirubin (1000 mg/kg: 10.
69 µmol/L vs.
control: 22.
58 µmol/L).
Conclusion : The validated safety profile of S.
mombin hydroethanolic leaf extract supports its continued ethnomedicinal use and highlights its promise as a candidate for further pharmacological development—particularly as a potential hematinic, anti-infective, and hepatoprotective agent.

Related Results

Spondias mombin Ameliorates Copper‐Induced Memory Impairment in Mice by Mitigating Oxidative Stress and Modulating Cholinergic Activity
Spondias mombin Ameliorates Copper‐Induced Memory Impairment in Mice by Mitigating Oxidative Stress and Modulating Cholinergic Activity
The study unveils the importance of Spondias mombin leaf extract (S. mombin: 100 mg/kg b.wt.) in mitigating the toxic insult mediated by copper (16 mg/kg) on the cholinergic system...
Thematic group analysis of selected matridonal remedies
Thematic group analysis of selected matridonal remedies
Group analyses of homoeopathic remedies is a relatively new methodology, linking biologically related substances via their common symptomatology. At a very basic level of understan...
α-Amylase Inhibitory Potential of Antidiabetes Ligands in Spondias Mombin Plant Extract: Molecular Docking and ADMET Profiling
α-Amylase Inhibitory Potential of Antidiabetes Ligands in Spondias Mombin Plant Extract: Molecular Docking and ADMET Profiling
Diabetes mellitus is majorly characterised by hyperglycemia, resulting from the disturbance of glucose homeostasis in the body due to excess calories of dietary sugar. α-amylase en...
POTENCIAL TERAPÊUTICO E ATIVIDADES BIOLÓGICAS DA SPONDIAS mombin: REVISÃO DE ESCOPO
POTENCIAL TERAPÊUTICO E ATIVIDADES BIOLÓGICAS DA SPONDIAS mombin: REVISÃO DE ESCOPO
Spondias mombin L. da família Anacardiaceae é nativa do Brasil. Encontrada principalmente nas regiões Norte e Nordeste e com crescente demanda por suas frutas e produtos industrial...
PHARMACOLOGY OF SPONDIAS MOMBIN IN LIVER CANCER TREATMENT AND TOXICITY EVALUATION
PHARMACOLOGY OF SPONDIAS MOMBIN IN LIVER CANCER TREATMENT AND TOXICITY EVALUATION
Cancer is among the major causes of death in the world. Spondias mombin is a natural product being accepted as medication for many diseases. This research aimed at evaluating the t...
Evaluation of the acute toxicity of the total aqueous extract of the stem bark of Spondias mombin L. in Wister strain rats
Evaluation of the acute toxicity of the total aqueous extract of the stem bark of Spondias mombin L. in Wister strain rats
Background: Many medicinal plants including Spondias mombin L are used in traditional medicine for treatment of many pathology. It is therefore used for rational for remedies deriv...

Back to Top